Delivery Order SPE2DB20D2104-SPE2DB25FMTNT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of OxyContin ER 30 mg tablets (100-count units) valued at $5,750.52. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by June 6, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,321.72 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of OxyContin ER 30 mg tablets (100-count packages). This is a firm fixed price, non-set-aside contract with a completion date of August 27, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of OxyContin ER 30 mg tablets (100-count units) with a ceiling value of $1,079.46. This firm fixed-price delivery order, with an ultimate completion date of June 2, 2025, represents a non-competitive set-aside procurement and leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a $999.99 billion pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of OxyContin ER 30 mg tablets (100 count) with a contract value of $7,759.02. This is a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and represents a non-set-aside competitive award. The pharmaceutical supply will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,194.12 on August 14, 2025, for OxyContin ER 30 mg tablets (100-count supply). This firm fixed price, non-set-aside contract is part of AmerisourceBergen's broader engagement with the DLA and represents a delivery order issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of OxyContin ER 30 mg tablets in quantities of 100 units, with a ceiling value of $3,636.39. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award under open market conditions. The order is scheduled for completion by September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 5, 2025, for the supply of OxyContin ER 10 mg tablets (100-count units) with a contract ceiling value of $1,824.59. This is a firm fixed-price delivery order with an ultimate completion date of May 6, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 27, 2025, for OxyContin ER 30 mg tablets (100-count units) with a ceiling value of $1,717.40. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 28, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $3,215.82, represents a non-competitive set-aside contract with an ultimate completion date of July 28, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units) with a contract value of $2,783.05. This delivery order represents a firm fixed price, non-set-aside competitive award supporting federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order is issued under...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMTNTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of OxyContin ER 30 mg tablets (100-count units) with a ceiling value of $1,439.28. This firm fixed-price delivery order, with an ultimate completion date of June 20, 2025, represents a non-competitive set-aside contract and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive IDC with the Defense Logistics Agency functions as a global pharmaceutical support vehicle enabling the supply of a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. This delivery order for controlled pharmaceutical inventory reflects the company's ongoing role in fulfilling federal medical supply requirements through its established prime vendor relationship with the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 6/18/25 |